Delivery Order SPE2DB22D3401-SPE2DB24FT1ZW
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $3,314.56 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The contract has a completion date of January 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,242.96 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The completion date for this order is February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $1,442.25 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,286.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM. This contract has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The award has a potential value of $2,357.21 and a completion date of February 27, 2024. This delivery order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,414,074 units of FLUTICASONE PROP HFA 44 MCG 10.6GM. The $1,161.90 order has a completion date of January 24, 2024 and was issued on January 23, 2024. This delivery order is part of Amerisourcebergen's broader contract to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. The company has...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,939.85 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. This delivery order contract has a performance period through January 29, 2024 and does not contain any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value...
- This is a $1,012.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a prescription medication. The award is not set aside and has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT1ZWDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc., was awarded a $1,693.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) on February 23, 2024. The order is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a completion date of February 26, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/23/24 |